^
    BIOMARKER:

    BCR-ABL1 fusion

    i
    Other names: BCR, BCR Activator Of RhoGEF And GTPase, BCR, RhoGEF And GTPase Activating Protein, Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, Breakpoint Cluster Region, D22S11, BCR1, BCR/FGFR1 Chimera Protein, FGFR1/BCR Chimera Protein, D22S662, ALL, CML, PHL, ABL proto-oncogene 1, ABL, c-ABL, JTK7, p150, ABL1




    Show legend

    Include preclinical:
    B Acute Lymphoblastic Leukemia
    Chronic Myeloid Leukemia
    Acute Lymphocytic Leukemia
    Acute Myelogenous Leukemia
    Leukemia
    Myelodysplastic Syndrome
    Tyrosine kinase inhibitor
    CAR-T immunotherapy
    CVAD + Tyrosine kinase inhibitor
    T-lymphocyte cell therapy
    blinatumomab
    brexucabtagene autoleucel
    imatinib
    dasatinib
    CAR-T immunotherapy + dasatinib
    olverembatinib
    ponatinib
    asciminib
    bosutinib
    etoposide IV
    ponatinib + blinatumomab
    flumatinib
    venetoclax + dasatinib
    inotuzumab ozogamicin
    nilotinib
    dasatinib + blinatumomab
    PD-L1 inhibitor + nilotinib
    venetoclax + flumatinib
    venetoclax + olverembatinib
    venetoclax + ponatinib
    SCO - 088
    dasatinib + asciminib
    blinatumomab + olverembatinib
    nilotinib + asciminib
    imatinib + asciminib
    bosutinib + inotuzumab ozogamicin
    venetoclax + nilotinib
    venetoclax + bosutinib
    KPT-8602
    dasatinib + nilotinib + S81694
    ponatinib + CUDC-907
    dasatinib + JNK-IN-8
    olaparib
    OSE-127
    aminoxyrone
    dasatinib + SBI-756
    S63845 + S55746
    ponatinib + GMX1778